Queen’s University Belfast Centre for Infection and Immunity
Queen’s University Belfast Centre for Infection and Immunity, The Centre for Infection and Immunity (CII) is an expanding collaborative interdisciplinary research Centre committed to the highest quality research excellence. Our mission is to build on our high-quality research programmes and to further develop our world-class research by recruiting others in the areas of infectious and inflammatory diseases. Our new Centre occupies a ‘state-of-the-art’ facility with space for 220 researchers and capacity for future expansion.
Our research is focused on Respiratory and Infectious disease, molecular Immunology and Autoimmune Disease. The Respiratory disease research strengths include Asthma, Respiratory Infection, Cough, Acute Lung Injury and Cystic Fibrosis. The hallmark of our research programme is a close, collaborative interaction between clinical and basic science experts that ultimately enhances the quality and scope of our basic and clinical research programmes on infection and other important human diseases, such as lung and autoimmune diseases.
The use of human tissue for research purposes is governed by the Human Tissue Act 2004 and any subsequent amendments. This legislation regulates the removal, storage and use of human tissue defined as ‘relevant material’ that has come from a human body and consists of, or includes, human cells. The Human Tissue Authority (HTA) is the regulatory body which licences establishments storing and using relevant material for ‘scheduled purposes’ such as research or anatomical examination. The HTA has issued Codes of Practice which detail the standards expected from licenced establishments.
97 Lisburn Road
- Phone: 028 90 975876
- Fax: 028 90 972671